Gavin MacBeath
Director Ejecutivo en TSCAN THERAPEUTICS, INC. .
Fortuna: 362 801 $ al 30/04/2024
Cargos activos de Gavin MacBeath
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TSCAN THERAPEUTICS, INC. | Director/Miembro de la Junta | 24/05/2023 | - |
| Director Ejecutivo | 28/03/2023 | - | |
| Director de Operaciones | 01/06/2022 | 24/05/2023 | |
| Director Técnico/Científico/I+D | 01/12/2018 | 24/05/2023 | |
| Director Financiero/CFO | 21/07/2023 | 29/01/2024 |
Historial de carrera de Gavin MacBeath
Antiguos cargos conocidos de Gavin MacBeath.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ABPRO CORPORATION | Director Técnico/Científico/I+D | 01/03/2017 | 01/07/2018 |
| MERRIMACK PHARMACEUTICALS, INC. | Fundador | 01/01/1993 | 01/09/2017 |
| Corporate Officer/Principal | 13/07/2011 | 01/09/2017 | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/07/2002 | 01/06/2010 |
Formación de Gavin MacBeath.
| University of Manitoba | Undergraduate Degree |
| The Scripps Research Institute | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
| Canadá | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Founder | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| MERRIMACK PHARMACEUTICALS, INC. | Health Technology |
| TSCAN THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Gavin MacBeath
- Experiencia
